PBK_M2101

· Pharmbio Korea Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PBK_M2101, covering 2023-06-28 to 2023-06-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of PBK_M2101 [Phase 3]